SUO 2021

REVIEW UroToday

Viewing 1-20 of 51 articles

SUO 2021: Role of Focal Therapy for Localized Prostate Cancer: Point/Counterpoint Debate - Against Focal Therapy

SUO 2021: Role of Focal Therapy for Localized Prostate Cancer: Point/Counterpoint Debate - Focal Therapy Should Be Considered

SUO 2021: Hypofractionation in Unfavorable Risk Localized Disease: Status of the Evidence

SUO 2021: Expanding Active Surveillance - Considerations for Grade Group 2

SUO 2021: Adverse Prostate Cancer Pathological Variants: Considerations for Management

SUO 2021: Mitigating Infection Rates in Prostate Biopsy

SUO 2021: Smarter Screening - Integrating Emerging Polygenic Risk Scores and PSA Screening

SUO 2021: Should Transperineal Biopsy Be Standard of Care for Patients Undergoing Prostate Biopsy?

SUO 2021: Local Regional Anesthesia Considerations for Transperineal and Transrectal Prostate Biopsy

SUO 2021: Clinical Trials of Transperineal Prostate Biopsy

SUO 2021: Integrating Transperineal Prostate Biopsy Into the Clinic: Logistical Considerations for Practice

SUO 2021: Our Specialty, Our Society and Our Patients -- Moving Beyond Ambition to Organizational Competency from a US Health System Perspective

SUO 2021: Improving Detection of Clinically Significant Cancer

SUO 2021: Should Transperineal Biopsy Be Standard of Care?

SUO 2021: Health Information Technology to Improve Clinical Processes and Patient Care

SUO 2021: State of the Art: Molecular Classification of Upper Tract Urothelial Carcinoma

SUO 2021: Integration of Somatic and Germline Next Generation Sequencing Results into Clinical Management of Patients with Advanced Prostate Cancer

SUO 2021: Does the Evidence Justify Extrapolating the Benefit of Neoadjuvant Chemotherapy from Bladder Cancer to Upper Tract Urothelial Carcinoma?

SUO 2021: Limited Versus Extended Lymph Node Dissection: Point/Counterpoint

SUO 2021: Emerging Biomarkers to Identify Patients with High-Risk Non-Metastatic Renal Cell Carcinoma

1
2
3